D'AMICO LANCE E

D'Amico sells 50,000 APH shares at $149.88 (Feb 18); holds 57,065 after; stock at $151.20; his 5 prior APH sales all posted +90d gains.

D'Amico Lance E sold 50,000 shares of Amphenol Corp at $149.88 on 2026-02-18, reducing his stake by 46.7% to 57,065 shares, worth $7,494,155.00. His trading history at Amphenol is notable: across 5 prior sales at this ticker, every single transaction was followed by positive 90-day returns, ranging from +0.6% to +36.9%, meaning he has consistently sold before periods of appreciation. This current sale occurs with the stock at $151.20, only 9.0% below its 52-week high of $166.25 and up 14.9% over the past 90 days. The company posts solid fundamentals with $6.2B in quarterly revenue, $1.2B net income, and 51.7% annual revenue growth, though the P/E of 32.80 reflects a premium valuation. The insider's historical pattern at this ticker—where none of his 5 prior sales proved well-timed at the 90-day mark—contrasts sharply with typical bearish insider-sell interpretation, suggesting either portfolio rebalancing or systematic scheduled activity rather than a conviction-based directional signal.

Sr. VP D'Amico sells 120,000 APH shares for $16.8M; reduces holdings 61.1% to 76.4K shares

D'Amico sold 120,000 shares at $140.01 on 2025-10-29, reducing his position by 61.1% from 196,400 to 76.4K shares for total proceeds of $16,801,548.00. The sale occurred near the 52-week high (-0.5% from $139.75) and follows a strong recent run (+12.4% over 30 days, +33.4% over 90 days). Notably, his prior trades at APH have not demonstrated a pattern of well-timed selling—0 of 3 prior measurable 90-day outcomes showed negative returns post-sale, indicating the stock typically rose after he sold at this ticker. His cross-ticker track record shows only a 44.44% well-timed rate with an average 90-day return of -3.4% post-sell, suggesting minimal predictive value historically. With APH trading at a P/E of 44.59 and the company reporting strong fundamentals (revenue $6.2B, +21.2% annual growth, net income $1.2B), this substantial reduction warrants attention as a data point, though the historical pattern offers limited evidence of insider foresight into near-term price direction.

Sr. VP D'Amico sells 130,000 APH shares for $14.4M, reducing stake by 63% to 76.4K shares

Lance D'Amico, Sr. VP, Secretary & General Counsel, executed 2 separate sales totaling 130,000 shares for $14,384,279.00 at a blended average price of $110.65 on 2025-08-18, reducing his holdings from 206,400 to 76.4K shares—a 63% reduction in stake size. The stock currently trades at $109.98, within 1.7% of its 52-week high of $111.85, and has appreciated 28.4% over the past 90 days and 6.4% over 30 days. His prior sales at APH show mixed timing results: 4 of 5 prior trades resulted in subsequent 90-day gains (avg +16.0% across those four), with only the 2024-10-30 sale well-timed at the 90-day mark. This sale occurs after a sustained rally in APH, and the substantial reduction in his personal exposure—from over 200K to under 77K shares—represents a material shift in insider positioning at a company with strong fundamentals ($5.7B in latest quarterly revenue, +21.2% annual growth).

Sr. VP D'AMICO sold 100,000 APH shares at $86.36 on 2025-05-13; holds 76,400 post-sale (-56.7%)

Lance E. D'AMICO, serving as Sr. VP, Secretary & General Counsel, executed a substantial open-market sale of 100,000 shares valued at $8,635,560.00, reducing his holdings from 176,400 to 76,400 shares—a -56.7% reduction in his position. The sale occurred at $86.36, matching the current 52-week high of $85.78, though the stock has appreciated 31.2% over the preceding 30 days and 23.0% over 90 days. Across his same-ticker history at APH, D'AMICO's prior measurable sells (5 trades total) show mixed outcomes: his 1 of 3 prior sells with 90-day results proved well-timed, while two recent sells on 2025-04-25 remain outcome-pending. His cross-ticker track record of 8 prior sells exhibits a 66.67% well-timed rate at the 90-day mark, with average 90-day returns of -21.9%, suggesting modest pattern of selling before subsequent declines. The company fundamentals remain strong—revenue of $4,811,000,000.00 with net income of $737,800,000.00 and annual revenue growth of +21.2%—though the P/E of 39.71 reflects elevated valuation at the stock's 52-week peak.

Sr. VP D'Amico sells entire 205,000-share position at blended $76.27; zero shares retained post-transaction.

D'Amico, Sr. VP, Secretary & General Counsel, executed 2 separate sales totaling 205,000 shares for $15,635,625.50 on 2025-04-25, reducing his holdings from 205,000 shares to zero. The blended average sale price was $76.27, near the current price of $76.68, and within the 52-week range of $58.16–$78.55. His prior trades at APH show mixed outcomes: 3 of 5 prior sells were well-timed at the 90-day mark, though 2 recent 2024 sales (July 26, August 15, October 30) each posted positive 90-day returns, indicating the stock rose after those sales. The complete liquidation of a senior executive's full position warrants attention, though the absence of any residual shares limits the ability to infer ongoing conviction. Stock momentum has been positive in the near term (+15.2% over 30 days), while the company reports solid fundamentals with annual revenue growth of +21.2% and net income of $737,800,000.00 on quarterly revenue of $4,811,000,000.00.

Sr. VP D'AMICO sells 75,000 shares of APH for $5.2M; holdings reduced 49.5%; stock near 52-week high at sale.

D'AMICO, as Sr. VP, Secretary & General Counsel, sold 75,000 shares (75.0K shares) on 2024-10-30 at $68.80, reducing his holdings from 151,400 shares to 76,400 shares—a 49.5% reduction in his position. The sale occurred when APH was trading -4.8% from its 52-week high of $70.41, suggesting the insider liquidated a substantial portion near the upper range of recent valuations. At the same-ticker level, his prior sells at APH have demonstrated a 75% well-timed rate at the 90-day mark; 3 of his 4 prior measurable sales at APH preceded declines of -3.1% to -54.8% over 90 days, though the most recent sale on 2024-08-15 showed only -3.1% 30-day performance. The company's fundamentals show stable scale (Revenue $4.0B, Net income $604.4M) but modest annual revenue growth of -0.5% and an elevated P/E of 36.82, indicating the stock may be pricing in expectations not yet supported by current operating trajectory.

Sr. VP/General Counsel D'Amico sells 100,000 APH shares ($6.6M) at $65.63; reduces holdings -66.1% to 51.4K

D'Amico, Amphenol's Sr. VP, Secretary & General Counsel, executed a substantial sale of 100,000 shares worth $6,563,040.00 on 2024-08-15, reducing his holdings from 151,400 shares to 51.4K shares—a -66.1% decline in stake. This represents his largest single transaction relative to remaining position and follows a pattern: his prior trades at APH (3 of 3 measurable sells) posted 90-day returns of -51.4%, -51.4%, and -39.6%, all negative, and his cross-ticker track record across 4 prior sells shows a 100.00% well-timed rate at the 90-day mark with average 90d return of -49.7%. The current price of $65.80 is only -6.6% below the 52-week high of $70.41 and the stock has moved +2.5% in the trailing 30 days, indicating the sale occurred near a peak in recent pricing. The fundamental context shows a mature business (P/E 37.60, $3.6B revenue, -0.5% annual growth) where the transaction occurs at relatively strong valuation levels.

D'AMICO LANCE E sold 90,000 (90.0K shares) APH at $64.65; post-transaction holdings 51,400 (51.4K shares), down 63.6%

D'AMICO LANCE E, Sr. VP, Secretary & General Counsel, executed a substantial sale of 90,000 shares at $64.65 on 2024-07-26, reducing his holdings from 141,400 to 51,400 shares—a 63.6% reduction in his position. Historically, this insider's three prior sales at APH each delivered negative 90-day returns: -39.6%, -54.8%, and -54.8%, establishing a consistent timing pattern where he sold before subsequent declines (100% well-timed rate across these three trades). Current price is $61.94, down 8.1% over 30 days and down 12.0% from the 52-week high of $70.41, suggesting the transaction may be tracking toward another well-timed outcome. Against this backdrop, a company with flat revenue growth (-0.5% year-over-year) and a P/E of 35.39 warrants observation, especially given this senior officer's demonstrated ability to exit before market weakness.